The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Narcolepsy Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. ... These sleep periods can range from seconds or minutes and in most extreme cases sometimes hours at one time.
The global Narcolepsy Therapeutics market size is expected to reach US$ 3291.2 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Narcolepsy Therapeutics in various end use industries. The expanding demands from the Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy and Secondary Narcolepsy,, are propelling Narcolepsy Therapeutics market. Central nervous system stimulants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sodium Oxybate segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Narcolepsy Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Narcolepsy Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Narcolepsy Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Narcolepsy Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Narcolepsy Therapeutics covered in this report include Addrenex Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Jazz Pharmaceuticals PLC, Graymark Healthcare, Inc., Arena Pharmaceuticals, Inc., BIOPROJET, Takeda and Ligand Pharmaceuticals, Inc., etc.
The global Narcolepsy Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Addrenex Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals PLC
Graymark Healthcare, Inc.
Arena Pharmaceuticals, Inc.
BIOPROJET
Takeda
Ligand Pharmaceuticals, Inc.
Global Narcolepsy Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Narcolepsy Therapeutics market, Segment by Type:
Central nervous system stimulants
Sodium Oxybate
Selective Serotonin Reuptake Inhibitor (SSRI)
Tricyclic Antidepressants
Others
Global Narcolepsy Therapeutics market, by Application
Narcolepsy With Cataplexy
Narcolepsy Without Cataplexy
Secondary Narcolepsy
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Narcolepsy Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. ... These sleep periods can range from seconds or minutes and in most extreme cases sometimes hours at one time.
The global Narcolepsy Therapeutics market size is expected to reach US$ 3291.2 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Narcolepsy Therapeutics in various end use industries. The expanding demands from the Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy and Secondary Narcolepsy,, are propelling Narcolepsy Therapeutics market. Central nervous system stimulants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sodium Oxybate segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Narcolepsy Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Narcolepsy Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Narcolepsy Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Narcolepsy Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Narcolepsy Therapeutics covered in this report include Addrenex Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Jazz Pharmaceuticals PLC, Graymark Healthcare, Inc., Arena Pharmaceuticals, Inc., BIOPROJET, Takeda and Ligand Pharmaceuticals, Inc., etc.
The global Narcolepsy Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Addrenex Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals PLC
Graymark Healthcare, Inc.
Arena Pharmaceuticals, Inc.
BIOPROJET
Takeda
Ligand Pharmaceuticals, Inc.
Global Narcolepsy Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Narcolepsy Therapeutics market, Segment by Type:
Central nervous system stimulants
Sodium Oxybate
Selective Serotonin Reuptake Inhibitor (SSRI)
Tricyclic Antidepressants
Others
Global Narcolepsy Therapeutics market, by Application
Narcolepsy With Cataplexy
Narcolepsy Without Cataplexy
Secondary Narcolepsy
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Narcolepsy Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Narcolepsy Therapeutics
1.1 Narcolepsy Therapeutics Market Overview
1.1.1 Narcolepsy Therapeutics Product Scope
1.1.2 Narcolepsy Therapeutics Market Status and Outlook
1.2 Global Narcolepsy Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Narcolepsy Therapeutics Market Size by Region (2018-2029)
1.4 Global Narcolepsy Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Narcolepsy Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Narcolepsy Therapeutics Market Size (2018-2029)
1.6.1 North America Narcolepsy Therapeutics Market Size (2018-2029)
1.6.2 Europe Narcolepsy Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Narcolepsy Therapeutics Market Size (2018-2029)
1.6.4 Latin America Narcolepsy Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Narcolepsy Therapeutics Market Size (2018-2029)
2 Narcolepsy Therapeutics Market by Type
2.1 Introduction
2.1.1 Central nervous system stimulants
2.1.2 Sodium Oxybate
2.1.3 Selective Serotonin Reuptake Inhibitor (SSRI)
2.1.4 Tricyclic Antidepressants
2.1.5 Others
2.2 Global Narcolepsy Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Narcolepsy Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Narcolepsy Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Narcolepsy Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Narcolepsy Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Narcolepsy Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Narcolepsy Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Narcolepsy Therapeutics Revenue Breakdown by Type (2018-2029)
3 Narcolepsy Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Narcolepsy With Cataplexy
3.1.2 Narcolepsy Without Cataplexy
3.1.3 Secondary Narcolepsy
3.2 Global Narcolepsy Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Narcolepsy Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Narcolepsy Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Narcolepsy Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Narcolepsy Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Narcolepsy Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Narcolepsy Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Narcolepsy Therapeutics Revenue Breakdown by Application (2018-2029)
4 Narcolepsy Therapeutics Competition Analysis by Players
4.1 Global Narcolepsy Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Narcolepsy Therapeutics as of 2022)
4.3 Date of Key Players Enter into Narcolepsy Therapeutics Market
4.4 Global Top Players Narcolepsy Therapeutics Headquarters and Area Served
4.5 Key Players Narcolepsy Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Narcolepsy Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Addrenex Pharmaceuticals, Inc.
5.1.1 Addrenex Pharmaceuticals, Inc. Profile
5.1.2 Addrenex Pharmaceuticals, Inc. Main Business
5.1.3 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Products, Services and Solutions
5.1.4 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Addrenex Pharmaceuticals, Inc. Recent Developments
5.2 Teva Pharmaceutical Industries Ltd.
5.2.1 Teva Pharmaceutical Industries Ltd. Profile
5.2.2 Teva Pharmaceutical Industries Ltd. Main Business
5.2.3 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Products, Services and Solutions
5.2.4 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Teva Pharmaceutical Industries Ltd. Recent Developments
5.3 Jazz Pharmaceuticals PLC
5.3.1 Jazz Pharmaceuticals PLC Profile
5.3.2 Jazz Pharmaceuticals PLC Main Business
5.3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Products, Services and Solutions
5.3.4 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Graymark Healthcare, Inc. Recent Developments
5.4 Graymark Healthcare, Inc.
5.4.1 Graymark Healthcare, Inc. Profile
5.4.2 Graymark Healthcare, Inc. Main Business
5.4.3 Graymark Healthcare, Inc. Narcolepsy Therapeutics Products, Services and Solutions
5.4.4 Graymark Healthcare, Inc. Narcolepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Graymark Healthcare, Inc. Recent Developments
5.5 Arena Pharmaceuticals, Inc.
5.5.1 Arena Pharmaceuticals, Inc. Profile
5.5.2 Arena Pharmaceuticals, Inc. Main Business
5.5.3 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Products, Services and Solutions
5.5.4 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Arena Pharmaceuticals, Inc. Recent Developments
5.6 BIOPROJET
5.6.1 BIOPROJET Profile
5.6.2 BIOPROJET Main Business
5.6.3 BIOPROJET Narcolepsy Therapeutics Products, Services and Solutions
5.6.4 BIOPROJET Narcolepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 BIOPROJET Recent Developments
5.7 Takeda
5.7.1 Takeda Profile
5.7.2 Takeda Main Business
5.7.3 Takeda Narcolepsy Therapeutics Products, Services and Solutions
5.7.4 Takeda Narcolepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Takeda Recent Developments
5.8 Ligand Pharmaceuticals, Inc.
5.8.1 Ligand Pharmaceuticals, Inc. Profile
5.8.2 Ligand Pharmaceuticals, Inc. Main Business
5.8.3 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Products, Services and Solutions
5.8.4 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Ligand Pharmaceuticals, Inc. Recent Developments
6 North America
6.1 North America Narcolepsy Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Narcolepsy Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Narcolepsy Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Narcolepsy Therapeutics Market Dynamics
11.1 Narcolepsy Therapeutics Industry Trends
11.2 Narcolepsy Therapeutics Market Drivers
11.3 Narcolepsy Therapeutics Market Challenges
11.4 Narcolepsy Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
